ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1393 National Cancer Institute Html en Cancer-Related Post-traumatic Stress (PDQ®)–Health Professional Version Expert-reviewed information summary about post-traumatic stress and related symptoms in cancer patients, cancer survivors, and their family members. Assessment and treatment of these symptoms are discussed.
traumatic event0.311819
cancer treatment0.301201
post-traumatic stress disorder0.298884
study0.281873
full-criteria PTSD group0.329802
PTSD trauma model0.338033
PTSD criteria0.318826
cancer experience0.272753
cancer treatment received.0.271124
intrusive thoughts0.407892
PTSD Checklist-Civilian Version0.325724
broad PTSD symptom0.316477
PTSD trauma0.338289
specific PTS symptoms0.273748
PTSD immediately postsurgery0.349332
PTSD symptoms0.490814
current PTSD0.319607
early-stage breast cancer0.412505
adult cancer patients0.298142
child cancer survivors0.27606
PTS symptoms0.347359
diagnostic criteria0.511308
PTSD patients0.326115
bone marrow transplant0.330974
mild-to-moderate cancer-related PTSD0.358971
structured clinical interview0.302585
PTSD-like symptoms0.416348
patients0.448951
cancer patients0.334316
post-traumatic symptoms0.263192
PTSD diagnostic criterion0.407584
breast cancer0.98286
DSM-IV PTSD syndrome0.373544
breast cancer survivors0.33396
acute stress disorder0.277841
lifetime PTSD0.33232
PTSD0.797398
symptoms0.617748
DSM-IV PTSD0.41474
PTSD module0.291206
cancer survivors0.345932
stress symptoms0.286797
metastatic breast cancer0.268733
precise PTSD symptoms0.406493
DSM-IV diagnostic criteria0.337351
early-stage cancer0.260629
CLICK HERE
1531 National Cancer Institute Html en Childhood Ependymoma Treatment (PDQ®)–Patient Version Expert-reviewed information summary about the treatment of childhood ependymoma.
cancer treatment0.626698
recurrent childhood ependymoma0.554401
following PDQ summaries0.501476
PDQ cancer information0.603175
high-grade cancer cells0.52438
clinical trial search0.497636
brain tumors0.624619
Childhood Ependymoma Treatment0.537776
clinical trials0.997686
Pediatric Treatment Editorial0.517454
cancer information summary0.560017
clinical trial0.708531
anaplastic ependymoma0.508455
patients0.511213
NCI PDQ cancer0.514722
brain stem0.532471
radiation therapy0.873758
Treatment Editorial Board0.522486
treatment0.865472
magnetic resonance imaging0.501265
childhood ependymoma0.915073
cancer cells0.900504
standard treatment0.509266
Cancer Information Service0.497532
intensity-modulated radiation therapy0.526143
PDQ Pediatric Treatment0.501585
Conformal radiation therapy0.512713
myxopapillary ependymoma0.509213
treatment clinical trials0.542772
National Cancer Institute0.559542
spinal cord0.912544
tumor cells0.497383
effects cancer treatment0.524938
proton-beam radiation therapy0.524248
new treatment0.578083
ependymoma forms0.516544
childhood cancer information0.507379
childhood brain tumors0.536709
external radiation therapy0.570552
treatment clinical trial0.51013
brain0.714551
PDQ summary0.496378
RELA fusion–positive ependymoma0.556789
cancer clinical trials0.531786
tumor0.709426
treatment options0.516335
cancer information summaries0.496292
comprehensive cancer information0.49561
cancer0.953861
CLICK HERE
1629 National Cancer Institute Html en Penile Cancer Treatment (PDQ®)–Patient Version Penile cancer is highly curable when found early. Find out about risk factors, symptoms, tests to diagnose, prognosis, staging, and treatment for penile cancer.
cancer treatment0.320382
biologic therapy0.30297
Lymph node dissection0.308565
tissue0.393322
erectile tissue0.338087
body0.324795
PDQ cancer information0.34528
clinical trial search0.382837
Penile Cancer Treatment0.305192
clinical trials0.721694
cancer information summary0.319238
clinical trial0.569243
Recurrent penile cancer0.32422
patients0.29378
lymph node biopsy0.446032
blood vessels0.32868
sentinel lymph node0.563667
spongy tissue0.289271
treatment clinical trial0.276059
NCI PDQ cancer0.28258
lymph nodes0.475166
radiation therapy0.416871
General information0.303882
general cancer information0.275537
treatment0.454305
wide local excision0.318281
tumor cells0.306254
new cancer treatments0.275369
NCI-supported cancer0.316489
cancer cells0.48036
Cancer Information Service0.276468
penile cancer0.671625
connective tissue0.347145
treatment clinical trials0.301804
National Cancer Institute0.364819
penis0.345276
lymph vessels0.289266
new treatment0.324645
metastatic penile cancer0.30082
cancer clinical trials0.389935
stage0.320852
tumor0.326492
cancer information summaries0.27434
comprehensive cancer information0.27491
internal radiation therapy0.325191
cancer0.921282
information0.35457
lymph ducts0.299322
standard treatment0.273177
CLICK HERE
1643 National Cancer Institute Html en Mistletoe Extracts (PDQ®)–Patient Version Mistletoe extracts have been studied in Europe as a treatment for many illness including cancer. Read about the use of mistletoe therapy in cancer patients and the results of clinical trials in this expert-reviewed summary.
cancer treatment0.498733
mistletoe extracts0.84177
European mistletoe species0.59742
cancer cell growth0.480977
Cancer Complementary0.499093
white blood cells0.478127
clinical trials0.814026
injectable mistletoe extracts0.584449
cancer information summary0.547122
alternative cancer therapies0.496047
National Center0.487589
CAM cancer research0.482862
mistletoe extract products0.586898
patients0.558663
cancer patients0.50887
body fight cancer0.488697
certain European countries0.486934
mistletoe0.936372
Integrative Health0.4867
NCI PDQ cancer0.515414
alternative medicine therapies0.509636
cancer information database0.494234
randomized clinical trials0.496538
Therapies Editorial Board0.492111
metastatic pancreatic cancer0.479516
mistletoe plant0.574134
injectable mistletoe0.604199
treatment0.516928
Complementary Therapies Editorial0.512225
human cancer cells0.481784
Drug Administration0.544399
Cancer Information Specialist0.48946
cancer cells0.492698
PDQ cancer information0.630287
Cancer Information Service0.543474
mistletoe extract0.769423
mistletoe dose0.56553
treatment clinical trials0.481986
National Cancer Institute0.675985
studies0.476699
alternative medicine0.586786
European mistletoe0.657219
mistletoe products0.583934
mistletoe lectins0.572067
cancer clinical trials0.506662
cell lung cancer0.478767
alternative therapies0.505915
cancer information summaries0.526674
CLICK HERE
1819 National Cancer Institute Html es Tratamiento del tumor de Wilms y otros tumores renales infantiles (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca del tratamiento del tumor de Wilms y otros tumores renales infantiles.
wilms tumor0.821427
wilms tumours0.50463
anomalías congénitas0.435681
gen blm0.427775
gen oncoinhibidor0.442787
gen oncosupresor h190.43309
gen drosha0.426257
anomalías cardíacas congénitas0.422372
Ahmed HU0.422578
tumores renales0.459976
gen ctr90.450784
gen cdkn1c0.42907
renal tumours0.428247
afección gen fenotipo0.433197
síndrome wagr0.961757
gen pax60.452923
Gen Wilms tumor0.633712
cánceres renales0.430685
síndrome congénito0.454197
Wilms Tumor Study0.602512
gen insulin growth0.431312
complejos génicos0.423036
anomalías renales0.500059
gen nsd10.428186
Beckwith-Wiedemann padecerán0.430165
Wilms Síndrome0.573396
gen wt10.557769
gen fbxw70.42494
Lancet Oncol0.427372
restos nefrógenos0.582325
Spring Harbor Laboratory0.432622
Cold Spring Harbor0.432647
síndromes wagr0.42334
gen ptch10.424282
efectos tardíos0.471463
tumor wilms0.630299
genes wt10.422664
dominio iiib0.434344
antecedentes familiares0.436654
Wilms anaplásico difuso0.515326
Wilms esporádico0.619115
mutaciones interruptoras0.593507
gen wtx0.481725
monoparental paterna0.424225
primary malignant non-wilms0.443665
gen tp530.452138
cánceres embrionarios.Las mutaciones0.471064
insuficiencia renal0.449112
células renales0.428025
CLICK HERE
1856 National Cancer Institute Html es Tratamiento del cáncer de nasofaringe (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca del tratamiento del cáncer de nasofaringe.
recurrent nasopharyngeal carcinoma0.314884
locoregionally advanced0.32749
T-stage nasopharyngeal carcinoma0.309795
advanced nasopharyngeal carcinoma0.746023
nasopharyngeal cancer0.331855
concurrent chemoradiotherapy0.311059
advanced squamous0.313322
randomized study0.31172
Radiat Oncol Biol0.67282
DeVita VT Jr0.315434
randomized trial0.419327
concurrent-adjuvant chemotherapy0.32145
chemotherapy with radiotherapy0.314748
Natl Cancer Inst0.315479
randomized trial comparing0.314639
treated with radiotherapy0.309308
undifferentiated nasopharyngeal carcinoma0.317213
patients with0.383207
metastatic nasopharyngeal carcinoma0.31503
radiation therapy0.346053
carcinoma treated with0.317616
with radiotherapy0.334247
Tung SY0.313347
Teo PM0.315435
preliminary results0.31387
eight randomized trials0.309618
radiotherapy with0.310444
nasopharyngeal carcinoma patients0.31096
prospective randomized0.316414
advanced undifferentiated carcinoma0.309346
nasopharyngeal carcinoma0.974941
Chan AT0.318151
chemotherapy vs radiotherapy0.31098
adjuvant chemotherapy with0.312314
local control0.310914
Clin Oncol0.499014
Werning JW0.309232
Oncol Biol Phys0.70745
locally-advanced nasopharyngeal carcinoma0.317916
primary nasopharyngeal carcinoma0.309776
neck cancer0.35727
American Joint Committee0.310074
with or without0.33621
locally advanced0.381657
T2 nasopharyngeal carcinoma0.309762
nasopharyngeal carcinoma treated0.317452
node-positive nasopharyngeal carcinoma0.317088
Cancer Study Group0.311102
induction chemotherapy0.311013
CLICK HERE
1882 National Cancer Institute Html es Tratamiento del ependimoma infantil (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca del tratamiento del ependimoma infantil.
Hielscher T0.367784
Grado III0.497368
prognostic factors0.418199
Merchant TE0.351136
Brain Tumor Registry0.358501
Korshunov A0.366815
spinal cord ependymomas0.397087
posterior fossa ependymoma0.679456
C11orf95-RELA fusions drive0.339744
líquido cefalorraquídeo0.413022
infratentorial childhood ependymomas0.36981
localized ependymoma0.366693
Radiat Oncol Biol0.730863
gen rela0.348774
Pediatric Brain Tumor0.377851
central nervous system0.408683
patients with0.480087
paediatric ependymoma0.378048
pediatric intracranial ependymoma0.417211
Acta Neuropathol0.362477
Mack SC0.397938
Retrospective Multicohort Analysis0.345199
cuarto ventrículo0.34367
United States0.381387
childhood ependymoma0.440498
intracranial ependymoma0.9229
Neuro Oncol0.422395
pediatric patients with0.359423
radioterapia posoperatoria0.479259
Pediatr Blood Cancer0.435451
myxopapillary ependymoma0.400108
spinal cord0.397509
supratentorial ependymoma0.360521
C11orf95-RELA fusions0.341174
ependymoma patients with0.34014
infantil recién0.356568
Clin Oncol0.43496
childhood intracranial ependymoma0.4276
sistema nervioso central0.476331
with intracranial ependymoma0.449085
Oncol Biol Phys0.751374
brain tumor0.436772
Witt H0.430118
Grado II0.78433
patients with localized0.344179
Central Brain Tumor0.357242
ependimoma infantil grupo0.387504
Childs Nerv Syst0.378828
Brain Tumor Consortium0.35913
CLICK HERE
1936 National Cancer Institute Html es Tratamiento de los tumores extracraneales de células germinativas en la niñez (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento de los tumores extracraneales de células germinativas en la niñez.
siguientes procedimientos0.383487
células madre0.843271
posibles factores0.316699
estadio iv0.881585
adultos jóvenes0.38604
siguientes áreas0.332444
afecciones quizás0.318252
Diferentes tipos0.319717
Estadio IIIC0.352194
siguientes tipos0.320718
tumores mixtos0.42367
rayos x0.344377
estadio ib0.390154
niño ayuda0.314653
efectos tardíos0.453508
PDQ Efectos tardíos0.33586
teratomas benignos0.329972
cm).estadio iiia0.314756
tarde.ampliar ecografía0.317174
National Cancer Institute0.311618
tumores benignos0.431931
IRMN).Ampliar Imágenes0.3138
estadio iic.estadio iia0.359243
siguientes lugares0.327905
germinomas.Los disgerminomas0.320088
siguientes riesgos0.31126
tratamiento quizás0.335386
Instituto Nacional0.320237
PDQ Tratamiento0.64104
células germinativas.Teratomas0.463139
estadio iiia0.352727
efectos tardíos quizás0.32327
células germinativas mixtos0.491909
siguientes marcadores0.329439
siguientes signos0.328509
nuevos tipos0.313861
saco vitelino0.360548
partes distantes0.338927
coriónica humana beta0.527277
Physician Data Query0.340834
sistema nervioso central0.331507
estadio iii0.993051
germinomas.Los tumores0.426016
tumoresde células0.36494
estadio ic.estadio ia0.359207
siguientes pruebas0.327352
marcadores tumorales.La0.319745
CLICK HERE
1966 National Cancer Institute Html es Tratamiento del cáncer de labio y de cavidad oral (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento del cáncer de labio y de cavidad oral.
medicamentos retinoides0.568081
siguientes procedimientos0.97932
siguientes elementos0.624752
estadio ii0.723086
rayos x0.572217
pequeñas marcas0.537003
estadio ivc0.583451
necesarios implantes0.546577
siguientes riesgos0.500736
malla ayuda0.53799
Instituto Nacional0.536147
área pequeña detrás0.642422
presente sección0.536306
partes distantes0.555475
Physician Data Query0.531283
estadio iii0.581263
libre uso0.500877
radioterapia hiperfraccionada0.899395
cáncer.ampliar radioterapia0.670655
Cancer Institute0.499502
siguientes enlaces0.516515
siguientes pruebas0.617318
Dientes flojos0.587562
pequeño espejo0.576408
siguientes estadios0.58645
CLICK HERE
3600 National Cancer Institute Html en NCI-COG Pediatric MATCH In this precision medicine clinical trial, children and adolescents with advanced cancers whose tumors have certain genetic mutations will be treated with drugs that are matched to those mutations.
histiocytoses—whose cancer0.377277
genetic makeup0.401588
university medical centers0.467884
brain tumors0.440585
blood sample0.480719
clinical trials0.534239
additional genetic testing0.511528
patients0.666156
new treatment arms0.480309
visit NCI0.372109
solid tumors0.469802
open treatment arms0.478804
tumor sample0.358797
Children’s Oncology0.616646
genomic sequencing0.508758
pediatric oncologist0.373126
genetic changes0.973154
precision medicine0.370826
Hereditary genetic changes0.524899
certain drugs0.381989
screening step0.630676
laboratory method0.368599
Pediatric MATCH0.671874
NCI-COG Pediatric MATCH0.543169
specific targeted drugs0.540831
nationwide cancer treatment0.58381
cancer cells0.393101
Cancer Information Service0.476816
pediatric patients0.406357
genetic counseling0.384583
Clinical Trials Network0.452506
enrollment steps0.358937
treatment arm0.797992
pediatric cancers0.526249
experimental drugs0.379128
genetic change0.798918
study drugs0.381585
contact NCI0.380025
health insurance plans0.447587
specific genetic changes0.498204
experimental treatment0.509457
certain genetic changes0.509656
cancer centers0.372633
cancer site0.501146
clinical trials search0.454345
tumors0.675099
cancer information specialists0.479605
Oncology Group0.642399
standard treatment0.375977
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.